Fertility warning
This medicine may affect fertility.
Leaflet FALVAX 250mg solution for injection in pre-filled syringe
- Product code:
- W64160002
- Quantity:
- 2
- Indicated for:
- breast cancer
- Route of administration:
- injectable
- Substance:
- fulvestrant (antineoplastic agent)
- ATC
- L02BA03 — Antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Anti-estrogens
Precautions:
Dose adjustment in hepatic impairment
Dose adjustment may be needed in liver disease.
Cytotoxic / special handling
Handle with special care.
Contraception required
Effective contraception is required during treatment.
Contraindicated during breastfeeding
Do not use this medicine while breastfeeding.
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Hepatotoxicity
This medicine may affect the liver.
Major drug interactions
This medicine may have important interactions with other medicines.
Myelosuppression / agranulocytosis
This medicine may lower blood cell counts.
Additional monitoring
This medicine is subject to additional monitoring.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Severe skin reactions
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
Fulvestrant is a medication used to treat advanced breast cancer in postmenopausal women, especially when the disease is hormone-sensitive. It works by blocking estrogen receptors on cancer cells, thereby preventing their growth and multiplication.
Fulvestrant is administered by intramuscular injection, usually once a month, under medical supervision. The dose and treatment schedule are determined by your doctor based on the stage of the disease and response to therapy. It is important to follow the treatment regularly to achieve the best results.
Side effects may include pain at the injection site, fatigue, nausea, bone or joint pain, and hot flashes. In rare cases, allergic reactions or changes in liver function may occur. Any unusual symptoms should be reported to your doctor immediately.
Fulvestrant is an effective option for controlling advanced breast cancer, but it requires careful medical monitoring. Follow your doctor's instructions and do not stop treatment without their approval to ensure the therapy's effectiveness and safety.
Fulvestrant is administered by intramuscular injection, usually once a month, under medical supervision. The dose and treatment schedule are determined by your doctor based on the stage of the disease and response to therapy. It is important to follow the treatment regularly to achieve the best results.
Side effects may include pain at the injection site, fatigue, nausea, bone or joint pain, and hot flashes. In rare cases, allergic reactions or changes in liver function may occur. Any unusual symptoms should be reported to your doctor immediately.
Fulvestrant is an effective option for controlling advanced breast cancer, but it requires careful medical monitoring. Follow your doctor's instructions and do not stop treatment without their approval to ensure the therapy's effectiveness and safety.
General data about FALVAX 250mg
- Substance:
- fulvestrant
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W64160002
- Concentration:
- 250mg
- Pharmaceutical form:
- solution for injection in pre-filled syringe
- Quantity:
- 2
- Product type:
- Generic medicine
- Price:
- 1068.89 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for fulvestrant
Concentrations available for fulvestrant
- 250mg
- 250mg/5ml